Marking Techniques for Target Lymph Nodes in Node-Positive Breast Cancer Treated With Neoadjuvant Therapy in the AXSANA/EUBREAST-03/AGO-B-053 Study

This large prospective analysis of patients with initially clinically node-positive BC receiving NACT demonstrates that probe-guided detection markers used to mark metastatic nodes before NACT provide superior detection rates.

Authors

Institutions

Publication Details

Journal
Journal of Clinical Oncology
Published
2026-01-21
DOI
https://doi.org/10.1200/jco-25-01921
Primary Topic
Breast Cancer Treatment Studies
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Marking Techniques for Target Lymph Nodes in Node-Positive Breast Cancer Treated With Neoadjuvant Therapy in the AXSANA/EUBREAST-03/AGO-B-053 Study

A Rief, Achim Rody, Marc Thill, Andraž Perhavec et al.
Journal of Clinical Oncology
Breast Cancer Treatment Studies
article

Marking Techniques for Target Lymph Nodes in Node-Positive Breast Cancer Treated With Neoadjuvant Therapy in the AXSANA/EUBREAST-03/AGO-B-053 Study

A Rief, Achim Rody, Marc Thill, Andraž Perhavec, Nikolas Tauber, Marian Vanhoeij, Elmar Stickeler, A Kothari, Douglas Zippel, Tomasz Berger, Franziska Ruf, Isabel T. Rubio, David Pinto, Natalia Krawczyk, E Schlichting, Michael Hauptmann, Eduard-Alexandru Bonci, Maria Luisa Gasparri, Steffi Hartmann, Zoltan Matrai, Kristina Wihlfahrt, Sarun Thongvitokomarn, Florentia Peintinger, Jennifer Schroth, Dawid Murawa, Timo Basali, Markus Hahn, Esther Schmidt, Michalis Kontos, Lukáš Dostálek, Katharina Jursik, Hagigat Valiyeva Qanimat, Geeta Kadayaprath, Rosa Di Micco, Mauro Porpiglia, Maggie Banys-Paluchowski, Beata Adamczyk, Tsvetomir Ivanov, Toralf Reimer, Sarah Fröhlich, Jana de Boniface, Oreste D Gentilini, Lia P Rebaza, Günay M Gürleyik, Michael Untch, Michael P Lux, Helidon Nina, Nina Ditsch, Hans-Christian Kolberg
article en

Abstract

This large prospective analysis of patients with initially clinically node-positive BC receiving NACT demonstrates that probe-guided detection markers used to mark metastatic nodes before NACT provide superior detection rates.

Journal of Clinical OncologyVol. 44(7)
Champalimaud Foundation (PT), Oslo University Hospital (NO), University of Medicine Tirana (AL), University of Helsinki (FI), Vita-Salute San Raffaele University (IT), University of Augsburg (DE), Azerbaijan Medical University (AZ), Universität Ulm (DE), Guy's and St Thomas' NHS Foundation Trust (GB), National and Kapodistrian University of Athens (GR), Medical University of Graz (AT), Iuliu Hațieganu University of Medicine and Pharmacy (RO), Charles University (CZ), Sheba Medical Center (IL), Helsinki University Hospital (FI), University Hospital Augsburg (DE), Karolinska Institutet (SE), Zonguldak Bülent Ecevit University (TR), Institute of Oncology Ljubljana (SI), Max Healthcare (IN), Queen Sirikit National Institute of Child Health (TH), Ospedale regionale di Lugano (CH), Ente Ospedaliero Cantonale (CH), Stuttgart Observatory (DE), Saint Göran Hospital (SE), Institute of Oncology Prof. Dr. Ion Chiricuta (RO), Ospedale Sant'Anna (IT), Greater Poland Cancer Center (PL), University Hospital Schleswig-Holstein (DE), National Heart Hospital (BG), Laiko General Hospital of Athens (GR), Marienhospital Bottrop (DE), Klinikum Esslingen (DE), Universitätsklinikum Aachen (DE), Breast Center (CH), EsSALUD (PE), University Children's Hospital Tübingen (DE), Haydarpaşa Numune Eğitim ve Araştırma Hastanesi (TR), Universitair Ziekenhuis Brussel (BE), Sağlık Bilimleri Üniversitesi (TR), Brüderkrankenhaus St. Josef Paderborn (DE), IRCCS Ospedale San Raffaele (IT), St. Josef Krankenhaus (DE), St. Vincenz-Krankenhaus Limburg (DE), Clinica Universidad de Navarra (ES), Medizinische Hochschule Brandenburg Theodor Fontane (DE), Agaplesion Markus Hospital (DE), Helios Hospital Berlin-Buch (DE), St. Anna Hospital (DE), Klinikum Stuttgart (DE), General University Hospital in Prague (CZ), Heinrich Heine University Düsseldorf (DE), University of Zielona Góra (PL), University of Rostock (DE), Hamad Medical Corporation (QA), Università della Svizzera italiana (CH), University of Lübeck (DE)
Good health and well-being
Openalex Percentile: Top 81%
Breast Cancer Treatment Studies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.